PMGC Holdings Inc. (NASDAQ:ELAB) Sees Significant Decline in Short Interest

PMGC Holdings Inc. (NASDAQ:ELAB) was the recipient of a large decrease in short interest in December. As of December 15th, there was short interest totaling 38,846 shares, a decrease of 31.4% from the November 30th total of 56,663 shares. Based on an average daily trading volume, of 442,173 shares, the days-to-cover ratio is currently 0.1 days. Approximately 5.7% of the shares of the company are sold short. Approximately 5.7% of the shares of the company are sold short. Based on an average daily trading volume, of 442,173 shares, the days-to-cover ratio is currently 0.1 days.

PMGC Stock Performance

Shares of PMGC stock traded down $0.09 during trading on Monday, reaching $1.46. 128,693 shares of the company’s stock were exchanged, compared to its average volume of 486,408. The company has a market cap of $992,120.00, a P/E ratio of -0.09 and a beta of 0.28. PMGC has a 1-year low of $1.45 and a 1-year high of $99.72. The firm’s 50-day moving average price is $4.74 and its 200 day moving average price is $6.00.

PMGC (NASDAQ:ELAB) last issued its quarterly earnings data on Friday, November 14th. The company reported ($4.95) earnings per share for the quarter. The company had revenue of $0.29 million during the quarter.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Wall Street Zen raised PMGC to a “sell” rating in a report on Saturday, October 25th. Weiss Ratings reaffirmed a “sell (e)” rating on shares of PMGC in a research report on Monday, December 15th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.